Announcements Trials
Browse Landscape

Phase

Phase NA 241Phase 1 106Phase 2 70Phase 1/2 56Phase EARLY_PHASE1 17Phase 3 16Phase 4 5Phase 2/3 5

Status

Completed 33Unknown 20Withdrawn 5Recruiting 5Terminated 3Active not recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 48Breast 36Genitourinary 30Lymphoid 20Other hematologic neoplasm 18Thoracic 17CNS 14Gynecologic 12Endocrine 10Plasma cell 9Head & Neck 9Dermatologic 7Classical hematology 7Tumor-Agnostic 5Other 5NET 4Myeloid 4Other solid neoplasm 3Sarcoma 2Other neoplasm 1

Conditions

Neoplasms 4Neoplasm Metastasis 1

Interventions

pembrolizumab 1olaparib 1durvalumab 1atezolizumab 1Trastuzumab 1Rituximab 1Platinum 1Nivolumab 1Ipilimumab 1Histamine H1 Antagonists 1Gemcitabine 1Dexamethasone 1Cobicistat 1Bevacizumab 1Balanced Anesthesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Tumor-Agnostic × Clear all
NCT06031233 2026-03-30

MINUTE

Isala

Phase 4 Recruiting
776 enrolled
Tumor-Agnostic

Neoplasms

NCT04281017 2026-01-16

Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients

University of Florida

Phase 4 Recruiting
40 enrolled
Tumor-Agnostic

Neoplasms

NCT06820255 2025-02-11

SELECTIO-UC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 4 Recruiting
135 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT06118710 2024-09-25

DEXASTOP

Erasmus Medical Center

Phase 4 Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

NCT05078671 2024-06-12

PROACTIVE

Radboud University Medical Center

Phase 4 Recruiting
160 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡